Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
UKALL14: Rituximab improves EFS in B-ALL, but four doses not enough
Rituximab may improve EFS in B-ALL regardless of Philadelphia chromosome status and CD20-positive expression level.
Article
APPRENTICE registry: Wide variation exists in acute pancreatitis treatment, outcomes
Despite recent major advances, some areas of the world lag behind the current evidence regarding the management of acute pancreatitis.
News
APPRENTICE registry: Wide variation exists in acute pancreatitis treatment, outcomes
Despite recent major advances, some areas of the world lag behind the current evidence regarding the management of acute pancreatitis.
News
Chemo-free induction-consolidation protocol for Ph+ ALL improved survival
ORLANDO – A front-line chemo-free induction-consolidation protocol for Ph+ ALL resulted in high survival and molecular response rates in the phase...
News
Cognitive problems after extremely preterm birth persist
Findings among 19-year-olds born extremely premature suggest cognitive and neuropsychological problems persist into early adulthood.
News
Delayed hospital admission after hip fracture raises mortality risk
Most studies focus on surgery timing among hospitalized patients and fail to consider preadmission waiting time.
News
Oral paclitaxel bests IV version for tumor response, neuropathy incidence in mBC
SAN ANTONIO – An oral formulation of paclitaxel given with the P-glycoprotein pump inhibitor encequidar improved...
News
First report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBC
SAN ANTONIO – Adding atezolizumab, an anti–programmed death-ligand 1 (PD-L1) monoclonal antibody, to neoadjuvant...
News
ASH releases guidelines on managing cardiopulmonary and kidney disease in SCD
ORLANDO – ASH has released the first of five new sets of sickle cell disease guidelines, with the first focusing on screening and management of...
News
APHINITY 6-year data: Benefit ongoing in HER2+ early BC, no significant OS benefit
Adding adjuvant pertuzumab to trastuzumab plus chemotherapy for HER2+ early breast cancer shows ongoing benefit vs. placebo at 6 years in the...
News
Oral arginine emerges as potential adjuvant for vaso-occlusive crisis management
ORLANDO – Researchers called for a phase 3, multicenter clinical trial to further evaluate the treatment.
News
Aspirin plus a DOAC may do more harm than good in some
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication...
News
Certolizumab may reduce uveitis flares, axSpA disease activity
ATLANTA – Certolizumab pegol shows multiple benefits – and improved benefit with earlier treatment – for axial spondyloarthritis.
News
TULIP trials show clinical benefit of anifrolumab for SLE
ATLANTA – Anifrolumab was well tolerated and provided clinical benefit for moderate-to-severe SLE in the global, phase 3 TULIP-1 and -2 trials.
News
Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis
ATLANTA – The selective JAK1 inhibitor upadacitinib had a rapid effect, with a clear difference emerging between the treatment and placebo groups...